Filing Flows › Sonoma Pharmaceuticals (SNOA) › Q1 FY27
Sonoma Pharmaceuticals (SNOA) Q1 FY27 earnings results (first quarter fiscal 2027)
10-Q filed Aug 6, 2026
Sonoma Pharmaceuticals (SNOA) reported revenue of $6.4M for the first quarter fiscal 2027 (Q1 FY27), +60% from a year earlier and +15% from the quarter before. Operating margin was -0.6%, net loss $330K (5.2% of revenue).
Sonoma Pharmaceuticals, Q1 FY27: revenue $6.4M (+60% year over year), operating margin -0.6%, net loss $330K, operating cash flow −$649K. The chart follows the revenue to costs, profit and cash.
| Q1 FY27 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.4M | +15% | +60% |
| Operating profit | −$40K | — | — |
| Net earnings | −$330K | — | — |
| Operating cash flow | −$649K | — | — |
What changed
Revenue was $6.4M in Q1 FY27, up 60% year over year and up 15% from the previous quarter.
Gross margin was 40.2%, up 3.8 points from Q1 FY26. Operating costs exceeded revenue by $40K, an operating margin of -0.6%. Operating expenses grew 2% against revenue growth of 60%. The quarter ended with a net loss of $330K, narrower than the previous quarter's $581K loss. Net interest and other expense of $290K was the main reason.
Operating cash flow was −$649K. Non-cash charges added back $32K of depreciation and amortization and $58K of share-based compensation. Working capital and other items used $409K. Capital expenditures of $2K exceeded it, leaving free cash flow of −$651K.
Questions
What was Sonoma Pharmaceuticals' revenue in the first quarter fiscal 2027?
Sonoma Pharmaceuticals (SNOA) reported revenue of $6.4M for the first quarter fiscal 2027 (Q1 FY27), +60% from a year earlier and +15% from the quarter before.
Was Sonoma Pharmaceuticals profitable in the first quarter fiscal 2027?
Operating loss was $40K (-0.6% of revenue) and net loss $330K.